EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Suspected Optic Nerve Dysfunction Associated with Semaglutide in a Non-Diabetic Obese Patient: A Case Report

Badeeya Rashid, Fareha Rasheed, Sibghatullah, Anwar Ahmed Wains

Journal of Diabesity · 13.02.2026 · 1 (2)

DOI: 10.66381/jod.2026.002 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Diabesity, online erschienen am 13.02.2026. Verfasst von Badeeya Rashid und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Semaglutide, a glucagon-like peptide-1 receptor agonist, is widely used for the treatment of type 2 diabetes mellitus and obesity. Although its safety profile is well established for common adverse effects, reports of neuro-ophthalmic complications remain limited. Case Presentation: A middle-aged non-diabetic obese man with a history of non-specific vasculitis and chronic lymphedema developed persistent bilateral blurred vision after initiation of semaglutide for weight management. He had no prior history of hypertension, dyslipidemia, or ocular disease. Comprehensive ophthalmologic examination was normal. Despite discontinuation of semaglutide, visual symptoms persisted. Neurologic evaluation raised concern for optic nerve involvement, although neuroimaging was inconclusive. Outcome: The temporal association with semaglutide exposure and the absence of alternative causes suggested a possible drug-associated neuro-ophthalmic adverse effect. The patient experienced psychological distress related to persistent visual impairment and weight regain.

Conclusion

This case highlights a potential association between semaglutide therapy and optic nerve–related visual disturbance in a non-diabetic patient. Clinicians should consider neuro-ophthalmic evaluation in patients receiving GLP-1 receptor agonists who develop new visual symptoms.

Zitieren

APA

Rashid, B., Rasheed, F., Sibghatullah, & Wains, A. A. (2026). Suspected Optic Nerve Dysfunction Associated with Semaglutide in a Non-Diabetic Obese Patient: A Case Report. Journal of Diabesity, 1(2). https://doi.org/10.66381/jod.2026.002

Vancouver

Rashid B, Rasheed F, Sibghatullah, Wains AA. Suspected Optic Nerve Dysfunction Associated with Semaglutide in a Non-Diabetic Obese Patient: A Case Report. Journal of Diabesity. 2026;1(2). doi:10.66381/jod.2026.002

BibTeX
@article{Rashid2026,
  author = {Rashid, Badeeya and Rasheed, Fareha and Sibghatullah and Wains, Anwar Ahmed},
  title = {Suspected Optic Nerve Dysfunction Associated with Semaglutide in a Non-Diabetic Obese Patient: A Case Report},
  journal = {Journal of Diabesity},
  year = {2026},
  volume = {1},
  number = {2},
  doi = {10.66381/jod.2026.002}
}
Kostenlos starten →